Cambridge Biomedical Inc

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website

Genosco, a Boston-based clinical stage biotech, specializes in discovering and developing novel kinase inhibitors to address unmet medical needs. Their experienced team focuses on kinase targeted therapies, leveraging the proprietary G-SMART™ platform to identify rare sequences and generate highly selective compounds swiftly. With a strong and diverse pipeline, including independent and partnered programs, Genosco boasts a proven track record supported by successful out-licensing partnerships. The G-SMART™ Platform stands out for mapping over 470 ATP binding sites of human kinases and maintaining a chemical library of 3,500+ master scaffolds for predictive modeling. Unified under a shared vision to enhance patients' quality of life, Genosco emphasizes strengthening their discovery platform through cutting-edge science. CEO John Koh advocates for fostering an open and positive work environment where employees can unleash their creativity fully, ensuring continued innovation in the field of kinase inhibitors. Generated from the website content

SpecialtiesDeveloping a therapeutic vaccine and companion diagnostic for celiac disease and other autoimmune diseases with a similar genetic background such as Type 1 Diabetes.